Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 9 | 2013 | 193 | 0.900 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 643 | 0.890 |
Why?
|
| Veterans | 8 | 2020 | 122 | 0.870 |
Why?
|
| United States Department of Veterans Affairs | 10 | 2024 | 33 | 0.860 |
Why?
|
| Primary Health Care | 8 | 2024 | 294 | 0.790 |
Why?
|
| Atherosclerosis | 3 | 2013 | 134 | 0.730 |
Why?
|
| Milk, Human | 5 | 2023 | 33 | 0.660 |
Why?
|
| Prediabetic State | 2 | 2014 | 53 | 0.530 |
Why?
|
| Middle Aged | 33 | 2024 | 10129 | 0.520 |
Why?
|
| Male | 47 | 2024 | 20025 | 0.470 |
Why?
|
| Cholesterol | 2 | 2013 | 205 | 0.470 |
Why?
|
| Hyperlipidemias | 2 | 2013 | 36 | 0.460 |
Why?
|
| Androgens | 1 | 2013 | 89 | 0.450 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 23 | 0.440 |
Why?
|
| Humans | 61 | 2024 | 37093 | 0.440 |
Why?
|
| Aging | 4 | 2013 | 664 | 0.440 |
Why?
|
| Aged | 25 | 2023 | 6741 | 0.430 |
Why?
|
| Quality of Health Care | 4 | 2016 | 138 | 0.410 |
Why?
|
| Insurance, Health | 1 | 2013 | 126 | 0.410 |
Why?
|
| United States | 22 | 2024 | 4223 | 0.410 |
Why?
|
| Female | 39 | 2024 | 20969 | 0.410 |
Why?
|
| Heart Failure | 3 | 2020 | 235 | 0.410 |
Why?
|
| Truth Disclosure | 1 | 2011 | 26 | 0.390 |
Why?
|
| Stereotyping | 1 | 2011 | 40 | 0.390 |
Why?
|
| Nicotine | 4 | 2024 | 257 | 0.360 |
Why?
|
| Electronic Health Records | 2 | 2024 | 66 | 0.360 |
Why?
|
| Adult | 22 | 2024 | 11712 | 0.350 |
Why?
|
| Social Support | 2 | 2012 | 394 | 0.340 |
Why?
|
| Lower Extremity | 2 | 2019 | 33 | 0.330 |
Why?
|
| Double-Blind Method | 9 | 2023 | 286 | 0.320 |
Why?
|
| Smoking Cessation | 3 | 2023 | 517 | 0.320 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2019 | 62 | 0.320 |
Why?
|
| Lipids | 3 | 2006 | 235 | 0.320 |
Why?
|
| Hypertension | 3 | 2021 | 796 | 0.310 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 404 | 0.290 |
Why?
|
| Health Services | 2 | 2009 | 57 | 0.290 |
Why?
|
| Telemedicine | 2 | 2020 | 182 | 0.290 |
Why?
|
| Muscle, Skeletal | 6 | 2006 | 282 | 0.270 |
Why?
|
| Medication Adherence | 2 | 2021 | 179 | 0.270 |
Why?
|
| Disease Management | 3 | 2019 | 61 | 0.270 |
Why?
|
| Blood Viscosity | 3 | 2021 | 4 | 0.270 |
Why?
|
| Parkinson Disease | 2 | 2019 | 178 | 0.260 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2018 | 26 | 0.260 |
Why?
|
| Patient-Centered Care | 2 | 2024 | 63 | 0.260 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2016 | 22 | 0.250 |
Why?
|
| Niacinamide | 1 | 2024 | 15 | 0.240 |
Why?
|
| Infant Formula | 2 | 2016 | 15 | 0.240 |
Why?
|
| Adolescent | 10 | 2023 | 5363 | 0.240 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 27 | 0.240 |
Why?
|
| Burnout, Professional | 1 | 2024 | 19 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 1609 | 0.230 |
Why?
|
| Hyperthyroidism | 1 | 2023 | 5 | 0.230 |
Why?
|
| Iodine | 1 | 2023 | 6 | 0.230 |
Why?
|
| Dietary Proteins | 2 | 2017 | 32 | 0.230 |
Why?
|
| Atrial Flutter | 1 | 2023 | 6 | 0.230 |
Why?
|
| Oligosaccharides | 1 | 2023 | 24 | 0.230 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2379 | 0.220 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2026 | 0.220 |
Why?
|
| Infant Nutritional Physiological Phenomena | 3 | 2016 | 36 | 0.220 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2002 | 13 | 0.220 |
Why?
|
| Sampling Studies | 1 | 2002 | 61 | 0.210 |
Why?
|
| Microcirculation | 2 | 2019 | 37 | 0.210 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 101 | 0.210 |
Why?
|
| Health Care Surveys | 1 | 2002 | 136 | 0.210 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 2721 | 0.210 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 14 | 0.200 |
Why?
|
| Fatty Liver | 2 | 2024 | 64 | 0.200 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2016 | 44 | 0.200 |
Why?
|
| Hypoglycemic Agents | 3 | 2023 | 160 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2018 | 1039 | 0.200 |
Why?
|
| Birth Weight | 4 | 2016 | 90 | 0.200 |
Why?
|
| Ischemic Attack, Transient | 1 | 2021 | 20 | 0.190 |
Why?
|
| HIV Infections | 3 | 2011 | 2303 | 0.190 |
Why?
|
| Young Adult | 5 | 2018 | 4268 | 0.190 |
Why?
|
| Tobacco Use Disorder | 1 | 2023 | 237 | 0.180 |
Why?
|
| Sulfonylurea Compounds | 1 | 2019 | 12 | 0.180 |
Why?
|
| Hydroxychloroquine | 1 | 2019 | 15 | 0.180 |
Why?
|
| California | 4 | 2012 | 476 | 0.180 |
Why?
|
| Mental Disorders | 2 | 2008 | 309 | 0.170 |
Why?
|
| Dementia | 2 | 2012 | 131 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2020 | 212 | 0.160 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 21 | 0.160 |
Why?
|
| Metformin | 1 | 2019 | 65 | 0.160 |
Why?
|
| Weight Gain | 3 | 2015 | 136 | 0.160 |
Why?
|
| Cushing Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
| Aspirin | 1 | 2018 | 49 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2018 | 45 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 284 | 0.160 |
Why?
|
| Depression | 2 | 2016 | 712 | 0.150 |
Why?
|
| Lanthanum | 1 | 2017 | 2 | 0.150 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 4 | 0.150 |
Why?
|
| Mass Screening | 3 | 2014 | 462 | 0.150 |
Why?
|
| Treatment Outcome | 6 | 2019 | 1369 | 0.150 |
Why?
|
| Caregivers | 2 | 2012 | 182 | 0.150 |
Why?
|
| Bone Diseases | 1 | 2017 | 18 | 0.150 |
Why?
|
| Prospective Studies | 7 | 2019 | 1378 | 0.150 |
Why?
|
| Benzamides | 1 | 2018 | 78 | 0.150 |
Why?
|
| Risk Factors | 5 | 2023 | 3562 | 0.150 |
Why?
|
| Body Composition | 2 | 2011 | 162 | 0.140 |
Why?
|
| Blood Pressure | 1 | 2021 | 646 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 485 | 0.140 |
Why?
|
| Food, Fortified | 2 | 2014 | 17 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 45 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2024 | 938 | 0.140 |
Why?
|
| Internet | 1 | 2018 | 211 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2016 | 62 | 0.140 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 68 | 0.140 |
Why?
|
| Infant, Premature | 2 | 2014 | 129 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 47 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2017 | 120 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2015 | 36 | 0.130 |
Why?
|
| Infant, Newborn | 5 | 2023 | 894 | 0.130 |
Why?
|
| Receptors, Androgen | 3 | 2006 | 126 | 0.130 |
Why?
|
| Drug Monitoring | 1 | 2015 | 14 | 0.130 |
Why?
|
| Stroke Volume | 1 | 2016 | 89 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 96 | 0.130 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 458 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2016 | 174 | 0.130 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 50 | 0.130 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 31 | 0.120 |
Why?
|
| Drug Resistance | 1 | 2015 | 99 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2006 | 534 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2015 | 55 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2016 | 238 | 0.120 |
Why?
|
| Breast Feeding | 1 | 2016 | 113 | 0.120 |
Why?
|
| Time Factors | 6 | 2019 | 1742 | 0.120 |
Why?
|
| Triglycerides | 2 | 2021 | 138 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2013 | 455 | 0.110 |
Why?
|
| Morphine Dependence | 1 | 2013 | 25 | 0.110 |
Why?
|
| Waist Circumference | 1 | 2014 | 89 | 0.110 |
Why?
|
| Health Promotion | 2 | 2019 | 653 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 54 | 0.110 |
Why?
|
| Insulin | 1 | 2015 | 236 | 0.110 |
Why?
|
| Drug Therapy, Combination | 3 | 2019 | 227 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 85 | 0.110 |
Why?
|
| Feeding Behavior | 2 | 2016 | 454 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2013 | 77 | 0.110 |
Why?
|
| Nurse Practitioners | 2 | 2021 | 14 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 268 | 0.110 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 13 | 0.100 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 16 | 0.100 |
Why?
|
| Medicaid | 1 | 2013 | 109 | 0.100 |
Why?
|
| Community Health Services | 1 | 2014 | 185 | 0.100 |
Why?
|
| Case Management | 1 | 2012 | 20 | 0.100 |
Why?
|
| Eating | 1 | 2013 | 166 | 0.100 |
Why?
|
| Dietary Fats | 2 | 2011 | 119 | 0.100 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2012 | 29 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 197 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 68 | 0.100 |
Why?
|
| Mental Health Services | 1 | 2012 | 118 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2020 | 1492 | 0.090 |
Why?
|
| Asthma | 1 | 2015 | 380 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2008 | 191 | 0.090 |
Why?
|
| Needs Assessment | 2 | 2009 | 170 | 0.090 |
Why?
|
| Vitamin D | 1 | 2012 | 196 | 0.090 |
Why?
|
| Infant | 4 | 2016 | 1046 | 0.090 |
Why?
|
| Hospitals, Veterans | 3 | 2007 | 15 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2007 | 68 | 0.090 |
Why?
|
| United States Indian Health Service | 1 | 2009 | 2 | 0.090 |
Why?
|
| Lactose | 1 | 2009 | 14 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2019 | 40 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 2 | 2006 | 41 | 0.080 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 61 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 854 | 0.080 |
Why?
|
| Cross-Over Studies | 2 | 2019 | 108 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2009 | 36 | 0.080 |
Why?
|
| Health Services Research | 1 | 2009 | 148 | 0.080 |
Why?
|
| Patient Care Management | 1 | 2008 | 6 | 0.080 |
Why?
|
| Bisexuality | 1 | 2011 | 208 | 0.080 |
Why?
|
| Quality of Life | 2 | 2023 | 481 | 0.080 |
Why?
|
| Mice | 5 | 2024 | 5913 | 0.080 |
Why?
|
| Sexual Partners | 1 | 2011 | 314 | 0.080 |
Why?
|
| Family Relations | 1 | 2008 | 46 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2008 | 76 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 974 | 0.080 |
Why?
|
| Risk-Taking | 1 | 2011 | 451 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2008 | 117 | 0.080 |
Why?
|
| Endarterectomy, Carotid | 1 | 2007 | 1 | 0.070 |
Why?
|
| Drug Administration Schedule | 3 | 2015 | 143 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 420 | 0.070 |
Why?
|
| Body Weight | 3 | 2014 | 434 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2007 | 73 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 43 | 0.070 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 18 | 0.070 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2006 | 8 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2016 | 41 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 97 | 0.070 |
Why?
|
| Demography | 1 | 2006 | 175 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2006 | 64 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2006 | 104 | 0.070 |
Why?
|
| Brain | 1 | 2013 | 1346 | 0.070 |
Why?
|
| Interviews as Topic | 3 | 2018 | 381 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2011 | 583 | 0.060 |
Why?
|
| Forecasting | 2 | 2003 | 128 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 242 | 0.060 |
Why?
|
| Postmenopause | 1 | 2005 | 128 | 0.060 |
Why?
|
| Leuprolide | 1 | 2004 | 8 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 17 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 385 | 0.060 |
Why?
|
| Animals | 6 | 2024 | 15081 | 0.060 |
Why?
|
| Hypogonadism | 1 | 2004 | 21 | 0.060 |
Why?
|
| Pertussis Vaccine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Bordetella pertussis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Whooping Cough | 1 | 2004 | 4 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2004 | 12 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2016 | 291 | 0.060 |
Why?
|
| Nurse's Role | 1 | 2004 | 31 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 560 | 0.060 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2018 | 4 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 583 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 109 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2023 | 17 | 0.060 |
Why?
|
| Energy Intake | 3 | 2011 | 170 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2003 | 8 | 0.060 |
Why?
|
| Leg | 1 | 2003 | 19 | 0.060 |
Why?
|
| Prebiotics | 1 | 2023 | 2 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2002 | 29 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2003 | 66 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 171 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2002 | 39 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 51 | 0.050 |
Why?
|
| Outpatients | 1 | 2002 | 33 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2006 | 484 | 0.050 |
Why?
|
| Lipoproteins, VLDL | 1 | 2021 | 3 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 225 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 885 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2015 | 353 | 0.050 |
Why?
|
| Dietary Supplements | 2 | 2014 | 208 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2021 | 64 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2002 | 221 | 0.050 |
Why?
|
| Exercise Test | 2 | 2016 | 67 | 0.050 |
Why?
|
| Liver | 1 | 2024 | 479 | 0.050 |
Why?
|
| Physician Assistants | 1 | 2021 | 14 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2021 | 38 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 441 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2021 | 47 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2021 | 41 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 905 | 0.050 |
Why?
|
| Los Angeles | 2 | 2015 | 380 | 0.050 |
Why?
|
| Medical Records | 2 | 2015 | 41 | 0.050 |
Why?
|
| Gender Identity | 1 | 2021 | 103 | 0.050 |
Why?
|
| Home Care Services | 1 | 2020 | 33 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 149 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 127 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 1418 | 0.040 |
Why?
|
| Sexual Behavior | 2 | 2021 | 609 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 64 | 0.040 |
Why?
|
| Guideline Adherence | 2 | 2012 | 84 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 923 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 372 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 677 | 0.040 |
Why?
|
| Antimalarials | 1 | 2019 | 55 | 0.040 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 10 | 0.040 |
Why?
|
| Exercise | 2 | 2021 | 613 | 0.040 |
Why?
|
| Physicians | 1 | 2021 | 163 | 0.040 |
Why?
|
| Nurses | 1 | 2019 | 48 | 0.040 |
Why?
|
| Smoking | 2 | 2022 | 940 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 220 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2018 | 40 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 97 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 935 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 58 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2018 | 78 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 1033 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 388 | 0.040 |
Why?
|
| Stroke | 1 | 2021 | 286 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 661 | 0.040 |
Why?
|
| Phosphorus | 1 | 2017 | 68 | 0.040 |
Why?
|
| Decision Trees | 1 | 2016 | 19 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2016 | 23 | 0.030 |
Why?
|
| Patient Admission | 1 | 2016 | 41 | 0.030 |
Why?
|
| Health Personnel | 1 | 2018 | 228 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2005 | 20 | 0.030 |
Why?
|
| Echocardiography | 1 | 2016 | 144 | 0.030 |
Why?
|
| Luteinizing Hormone | 2 | 2005 | 63 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2015 | 37 | 0.030 |
Why?
|
| Child | 2 | 2015 | 3131 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 61 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 313 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 477 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 623 | 0.030 |
Why?
|
| Drug Implants | 1 | 2013 | 21 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 33 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2013 | 28 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2013 | 57 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 212 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 898 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 1067 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2012 | 32 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 275 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 68 | 0.030 |
Why?
|
| Austria | 1 | 2012 | 4 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2012 | 32 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 107 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2012 | 18 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2012 | 59 | 0.030 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2012 | 29 | 0.030 |
Why?
|
| Texas | 1 | 2013 | 324 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2011 | 21 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2012 | 38 | 0.030 |
Why?
|
| Gestational Age | 1 | 2012 | 190 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 441 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 928 | 0.020 |
Why?
|
| Medicare | 1 | 2012 | 195 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 154 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2012 | 446 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2003 | 481 | 0.020 |
Why?
|
| Milk Banks | 1 | 2009 | 2 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1908 | 0.020 |
Why?
|
| Motivation | 1 | 2012 | 436 | 0.020 |
Why?
|
| Home Nursing | 1 | 2008 | 6 | 0.020 |
Why?
|
| Community Networks | 1 | 2008 | 108 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2008 | 94 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 2006 | 2 | 0.020 |
Why?
|
| Enema | 1 | 2006 | 10 | 0.020 |
Why?
|
| Myogenin | 1 | 2006 | 5 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2006 | 32 | 0.020 |
Why?
|
| Occult Blood | 1 | 2006 | 29 | 0.020 |
Why?
|
| Software | 1 | 2008 | 217 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 43 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2006 | 149 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2008 | 219 | 0.020 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2005 | 3 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2006 | 33 | 0.020 |
Why?
|
| Hematocrit | 1 | 2005 | 18 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 135 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 37 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 209 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2005 | 40 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2006 | 129 | 0.020 |
Why?
|
| Gels | 1 | 2005 | 42 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2005 | 88 | 0.020 |
Why?
|
| Biopsy | 1 | 2006 | 164 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 218 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2005 | 33 | 0.020 |
Why?
|
| Cell Division | 1 | 2006 | 307 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 59 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 380 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2004 | 12 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2004 | 10 | 0.020 |
Why?
|
| Drug Design | 1 | 2006 | 162 | 0.020 |
Why?
|
| Workload | 1 | 2004 | 22 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 58 | 0.020 |
Why?
|
| Prostate | 1 | 2005 | 154 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2004 | 82 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 562 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 893 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2004 | 132 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 349 | 0.010 |
Why?
|
| Thigh | 1 | 2003 | 11 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 58 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 708 | 0.010 |
Why?
|
| Hormones | 1 | 2003 | 55 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 75 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 70 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 157 | 0.010 |
Why?
|
| Vaccination | 1 | 2004 | 288 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 335 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 191 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 587 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 864 | 0.010 |
Why?
|